Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Andrea Serratore
Institution:
University at Buffalo, State University of New York
Observed institution:
University at Buffalo, State University of New York
ORCID:
0000-0003-0973-3270
Observed ORCID:
0000-0003-0973-3270
OpenAlex ID:
A5015530683
Comparative Proteomic Analysis Identifies Key Metabolic Regulators of Gemcitabine Resistance in Pancreatic Cancer
2022
·
Qingxiang Lin
, Shichen Shen
, et al.
·
Molecular & Cellular Proteomics
·
14
Fibroblast growth factor receptor 1 inhibition suppresses pancreatic cancer chemoresistance and chemotherapy-driven aggressiveness
2024
·
Qingxiang Lin
, Andrea Serratore
, et al.
·
Drug Resistance Updates
·
12
PDF
Expression of fibroblast growth factor receptor 1 correlates inversely with the efficacy of single‐agent fibroblast growth factor receptor‐specific inhibitors in pancreatic cancer
2023
·
Qingxiang Lin
, Andrea Serratore
, et al.
·
British Journal of Pharmacology
·
5
PDF
Abstract A117: Co-priming sonic hedgehog inhibitor sonidegib with plerixafor induces tumor microenvironment transformation that enhances fluorescent nanoparticle deposition in pancreatic tumor xenograft
2025
·
Jonathan R. Perri
, Andrea Serratore
, et al.
·
Cancer Research
Abstract PO-042: FGFR1 expression correlates inversely with the in vitro and in vivo efficacy of FGFR inhibitors in pancreatic cancer
2020
·
Qingxiang Lin
, Andrea Serratore
, et al.
·
Cancer Research
Show more works
View as search
Works count:
5
Citation count:
31
H-index:
3
I10-index:
2
Year
Topic
Type